• DOI:10.1159/000056351
• Corpus ID: 24302198

Tacalcitol, an Active Vitamin D3, Induces Nerve Growth Factor Production in Human Epidermal Keratinocytes

@article{Fukuoka2001TacalcitolAA,
  title={Tacalcitol, an Active Vitamin D3, Induces Nerve Growth Factor Production in Human Epidermal Keratinocytes},
  author={Masamichi Fukuoka and Katsutoshi Sakurai and Tomohiro Ohta and Mamoru Kiyoki and Ichiro Katayama},
  journal={Skin Pharmacology and Physiology},
  year={2001},
  volume={14},
  pages={226 - 233}
}

• M. Fukuoka, K. Sakurai, +2 authors I. Katayama
• Published 19 July 2001
• Biology
• Skin Pharmacology and Physiology

The human epidermal keratinocyte cell line K-TL-1, developed from a benign epidermal tumor, was cultured in the presence of the synthetic vitamin D3 analogue tacalcitol [1α,24(R)-dihydroxyvitamin D3] to assess the effects on the production of nerve growth factor (NGF). Confluent K-TL-1 cells were cultured with 10–8M of tacalcitol. Supernatants and cell homogenates were collected and NGF concentrations were determined by enzyme-linked immunosorbent assay. The concentration of NGF in the supernatants of cultures treated with tacalcitol peaked within 24 h after the start of tacalcitol treatment and remained stable for 96 h. This NGF induction caused by tacalcitol was dose-dependent, showing an ED50 between 10–10 and 10–9M. Induction of NGF mRNA expression by tacalcitol was also observed by RT-PCR, indicating that tacalcitol induced NGF expression through transcriptional activation. These results suggest that active vitamin D3 could treat peripheral neuropathy by inducing NGF production in the skin.